Wall Street Numbers logo
Wall Street Numbers logo
Wall Street Numbers
Neurocrine Biosciences, Inc. company logo
Neurocrine Biosciences, Inc. logo

Neurocrine Biosciences, Inc. (NBIX)

Profile

Company profile for Neurocrine Biosciences, Inc. (NBIX)
MetricValue
Full NameNeurocrine Biosciences, Inc.
TickerNASDAQ: NBIX
ExchangeNASDAQ
SectorHealthcare
IndustrySpecialty & Generic Drug Manufacturers
CountryUnited States
IPO
IndexesNot included
Websiteneurocrine.com
Employees1,800

Key Metrics

Neurocrine Biosciences, Inc. Key Details
MetricDateValue
Price$137.35
Price, 1D Change+1.00%
Market Cap$14B
-
PE Ratio32.80
Beta0.84
Revenue$2B
Revenue, 1Y Change+24.81%
EPS$3.29
EPS, 1Y Change+33.12%

Chart

Add series to chart(max: 6)
Series
SUGGESTED SERIES
Neurocrine Biosciences, Inc. chart

Events

Neurocrine Biosciences, Inc. Events
MetricDateValue
Next Earnings
Last Qtr. Earnings
Last Ann. Earnings
Last Ex-DividendN/AN/A
Next Ex-DividendN/AN/A
Last SplitN/AN/A
Next SplitN/AN/A
Last Ticker ChangeN/AN/A
Next Ticker ChangeN/AN/A

🔒 Log In To Unlock Full Data

Estimates

NBIX Estimates
MetricDateValue
EPS$3.29
EPS Estimate$6.92
EPS Est. Change+110.11%
Revenue$2.36B
Revenue Estimate$2.86B
Revenue Est. Change+21.24%
Current Price$137.35
Price Target-$180.00
Price Tgt. Change-+31.05%

🔒 Log In To Unlock Full Data

EPS

NBIX EPS reported versus estimate values
YearEstimateReportedSurprise / Exp.
$2.30$2.47+7.49%
$6.58$3.29-49.95%
$6.92N/A+110.11%
$9.17N/A+178.73%
NBIX EPS reported versus estimate values chart

Revenue

NBIX revenue reported versus estimate values chart
YearEstimateReportedSurprise / Exp.
$1.89B$1.89B-0.11%
$2.36B$2.36B-0.04%
$2.86BN/A+21.24%
$3.40BN/A+44.25%
NBIX revenue reported versus estimate values chart

🔒 Log In To Unlock Full Data

Performance

NBIX Performance
MetricDateValue
Price, 1Y+0.37%
Price, 3Y+11.65%
Market Cap, 1Y+0.67%
Market Cap, 3Y+15.36%
Revenue, 1Y+24.81%
Revenue, 3Y+107.79%
EPS, 1Y+33.12%
EPS, 3Y+259.62%

🔒 Log In To Unlock Full Data

Technical Indicators

NBIX Technical Indicators
MetricDateValue
Current Price$137.35
SMA 200$131.32
SMA 200 vs Price-4.39%
SMA 50$146.50
SMA 50 vs Price+6.66%
Beta0.84
ATR$3.89
14-Day RSI34.97
10-Day Volatility22.97%
1-Year Volatility37.60%

Dividends

NBIX Dividends
MetricDateValue
N/A-
UpcomingN/AN/A
-
-
Dividends Paid$0.00
Payout Ratio0.00%

🔒 Log In To Unlock Full Data

Income & Profitability

NBIX Income & Profitability
MetricDateValue
Revenue$2.36B
EPS$3.29
Gross Profit$2.30B
Gross Margin97.56%
Operating Profit$583.00M
Operating Margin25.35%
Net Income$341.30M
Net Margin14.49%
EBITDA$583.00M

🔒 Log In To Unlock Full Data

Financial Health

NBIX Financial Health
MetricDateValue
Debt To Equity0.00
Current Ratio3.40
Quick Ratio3.28
-
F-Score7
Altman Z-Score8.04

Valuations

NBIX Valuations
MetricDateValue
PE Ratio32.80
PS Ratio5.10
PB Ratio4.56
EV/EBITDA22.39
Enterprise ValueN/A-

Balance Sheet

NBIX Balance Sheet
MetricDateValue
Book Value$2.59B
Cash & Equivalents$233.00M
Total Assets$3.85B
Current Assets$1.72B
Total Liabilities$1.26B
Current Liabilities$507.70M
Total Debt$495.70M
Short Term Debt$40.60M
Accounts Payable$110.00M

Expenses

NBIX Expenses
MetricDateValue
Total Expenses$1.77B
Operating Expenses$1.74B
Cost Of Goods Sold$57.50M
SG&A$1.01B
D&A$27.10M
Interest Expense$0.00
Income Tax$144.70M

Cash Flow

NBIX Cash Flow
MetricDateValue
CFO$595.40M
CFI-$126.80M
CFF-$486.70M
Capex$38.20M
Free Cash Flow$557.20M

Recent analyst updates

NBIX Recent analyst updates
MetricDateValue
HC Wainwright & Co.→
Mizuho→
Stifel→
RBC Capital→
TD Cowen→
Morgan Stanley→
JP Morgan→
Truist Securities→
Stifel→
RBC Capital→

Analyst sentiment

Sentiment over the past month
NBIX analyst sentiment distribution chart

Institutional ownership

Largest institutional holders by ownership percentage
NBIX institutional ownership distribution chart

Screeners with NBIX

Data Sources & References

  1. NBIX Official Website www.neurocrine.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/914475/000091447525000181/0000914475-25-000181-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/914475/000091447525000037/0000914475-25-000037-index.htm
  4. NBIX Profile on Yahoo Finance finance.yahoo.com/quote/NBIX
  5. NBIX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nbix

FAQ

  • What is the ticker symbol for Neurocrine Biosciences, Inc.?

    The ticker symbol for Neurocrine Biosciences, Inc. is NASDAQ:NBIX

  • Does Neurocrine Biosciences, Inc. pay dividends?

    No, Neurocrine Biosciences, Inc. does not pay dividends

  • What sector is Neurocrine Biosciences, Inc. in?

    Neurocrine Biosciences, Inc. is in the Healthcare sector

  • What industry is Neurocrine Biosciences, Inc. in?

    Neurocrine Biosciences, Inc. is in the Specialty & Generic Drug Manufacturers industry

  • What country is Neurocrine Biosciences, Inc. based in?

    Neurocrine Biosciences, Inc. is headquartered in United States

  • When did Neurocrine Biosciences, Inc. go public?

    Neurocrine Biosciences, Inc. initial public offering (IPO) was on May 23, 1996

  • Is Neurocrine Biosciences, Inc. in the S&P 500?

    No, Neurocrine Biosciences, Inc. is not included in the S&P 500 index

  • Is Neurocrine Biosciences, Inc. in the NASDAQ 100?

    No, Neurocrine Biosciences, Inc. is not included in the NASDAQ 100 index

  • Is Neurocrine Biosciences, Inc. in the Dow Jones?

    No, Neurocrine Biosciences, Inc. is not included in the Dow Jones index

  • When was Neurocrine Biosciences, Inc. last earnings report?

    Neurocrine Biosciences, Inc.'s most recent earnings report was on October 28, 2025

  • When does Neurocrine Biosciences, Inc. report earnings?

    The next expected earnings date for Neurocrine Biosciences, Inc. is February 5, 2026